Annual EBIT
-$65.53 M
-$10.54 M-19.16%
December 31, 2023
Summary
- As of February 7, 2025, LYRA annual earnings before interest & taxes is -$65.53 million, with the most recent change of -$10.54 million (-19.16%) on December 31, 2023.
- During the last 3 years, LYRA annual EBIT has fallen by -$43.32 million (-195.05%).
- LYRA annual EBIT is now -802.71% below its all-time high of -$7.26 million, reached on December 31, 2018.
Performance
LYRA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$9.64 M
+$8.17 M+45.87%
September 30, 2024
Summary
- As of February 7, 2025, LYRA quarterly earnings before interest & taxes is -$9.64 million, with the most recent change of +$8.17 million (+45.87%) on September 30, 2024.
- Over the past year, LYRA quarterly EBIT has increased by +$7.19 million (+42.72%).
- LYRA quarterly EBIT is now -165.95% below its all-time high of -$3.62 million, reached on March 31, 2019.
Performance
LYRA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$67.44 M
+$7.19 M+9.63%
September 30, 2024
Summary
- As of February 7, 2025, LYRA TTM earnings before interest & taxes is -$67.44 million, with the most recent change of +$7.19 million (+9.63%) on September 30, 2024.
- Over the past year, LYRA TTM EBIT has dropped by -$4.55 million (-7.24%).
- LYRA TTM EBIT is now -1761.04% below its all-time high of -$3.62 million, reached on March 31, 2019.
Performance
LYRA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LYRA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.2% | +42.7% | -7.2% |
| 3 y3 years | -195.1% | +42.7% | -7.2% |
| 5 y5 years | -802.7% | +42.7% | -7.2% |
LYRA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.2% | at low | at high | +59.0% | -54.6% | +9.6% |
| 5 y | 5-year | -296.7% | at low | -126.9% | +59.0% | -308.3% | +9.6% |
| alltime | all time | -802.7% | at low | -165.9% | +59.0% | -1761.0% | +9.6% |
Lyra Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.64 M(-45.9%) | -$67.44 M(-9.6%) |
| Jun 2024 | - | -$17.80 M(-24.3%) | -$74.63 M(+4.0%) |
| Mar 2024 | - | -$23.52 M(+42.8%) | -$71.74 M(+9.5%) |
| Dec 2023 | -$65.53 M(+19.2%) | -$16.48 M(-2.1%) | -$65.53 M(+4.2%) |
| Sep 2023 | - | -$16.83 M(+12.8%) | -$62.89 M(+3.3%) |
| Jun 2023 | - | -$14.91 M(-13.9%) | -$60.89 M(+0.8%) |
| Mar 2023 | - | -$17.31 M(+25.1%) | -$60.38 M(+9.8%) |
| Dec 2022 | -$54.99 M(+26.1%) | -$13.84 M(-6.7%) | -$54.99 M(+0.4%) |
| Sep 2022 | - | -$14.83 M(+3.0%) | -$54.79 M(+7.3%) |
| Jun 2022 | - | -$14.40 M(+20.8%) | -$51.04 M(+7.0%) |
| Mar 2022 | - | -$11.93 M(-12.6%) | -$47.71 M(+9.4%) |
| Dec 2021 | -$43.62 M | -$13.64 M(+23.1%) | -$43.62 M(+17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$11.08 M(+0.1%) | -$37.03 M(+14.6%) |
| Jun 2021 | - | -$11.06 M(+41.3%) | -$32.31 M(+25.3%) |
| Mar 2021 | - | -$7.83 M(+11.0%) | -$25.79 M(+16.1%) |
| Dec 2020 | -$22.21 M(+34.4%) | -$7.05 M(+10.8%) | -$22.21 M(+13.6%) |
| Sep 2020 | - | -$6.36 M(+40.0%) | -$19.54 M(+12.3%) |
| Jun 2020 | - | -$4.54 M(+7.0%) | -$17.41 M(+1.5%) |
| Mar 2020 | - | -$4.25 M(-3.2%) | -$17.14 M(+3.8%) |
| Dec 2019 | -$16.52 M(+127.6%) | -$4.39 M(+3.8%) | -$16.52 M(+36.2%) |
| Sep 2019 | - | -$4.23 M(-1.3%) | -$12.13 M(+53.5%) |
| Jun 2019 | - | -$4.28 M(+18.1%) | -$7.91 M(+118.1%) |
| Mar 2019 | - | -$3.62 M | -$3.62 M |
| Dec 2018 | -$7.26 M | - | - |
FAQ
- What is Lyra Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Lyra Therapeutics?
- What is Lyra Therapeutics annual EBIT year-on-year change?
- What is Lyra Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly EBIT year-on-year change?
- What is Lyra Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Lyra Therapeutics?
- What is Lyra Therapeutics TTM EBIT year-on-year change?
What is Lyra Therapeutics annual earnings before interest & taxes?
The current annual EBIT of LYRA is -$65.53 M
What is the all time high annual EBIT for Lyra Therapeutics?
Lyra Therapeutics all-time high annual earnings before interest & taxes is -$7.26 M
What is Lyra Therapeutics annual EBIT year-on-year change?
Over the past year, LYRA annual earnings before interest & taxes has changed by -$10.54 M (-19.16%)
What is Lyra Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of LYRA is -$9.64 M
What is the all time high quarterly EBIT for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly earnings before interest & taxes is -$3.62 M
What is Lyra Therapeutics quarterly EBIT year-on-year change?
Over the past year, LYRA quarterly earnings before interest & taxes has changed by +$7.19 M (+42.72%)
What is Lyra Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of LYRA is -$67.44 M
What is the all time high TTM EBIT for Lyra Therapeutics?
Lyra Therapeutics all-time high TTM earnings before interest & taxes is -$3.62 M
What is Lyra Therapeutics TTM EBIT year-on-year change?
Over the past year, LYRA TTM earnings before interest & taxes has changed by -$4.55 M (-7.24%)